# Codex Review: medical_monitoring_p9_release_dossier_hash_exact_20260805

Date: 2026-08-05 19:48:00 +0800
Mode: Codex direct source-only review
Delegated-agent output: none; the direct Codex route was selected.

## Verdict

Pass for the bounded offline commercial release-dossier evidence hash
contract. Evidence hashes now require exact lowercase 64-hex bytes while
complete/partial dossier status and gate binding remain unchanged.

## Boundary Check

- Source and regression edits are confined to the offline release-dossier
  contract, its focused test and task-scoped evidence.
- No dossier file was generated or submitted, no release authority was
  granted, and no provider/runtime/browser/API login/real-project path was
  activated. The formal gate remains `read_only / blocked`; ports are empty.

## Codex Verification

- Focused release-dossier suite: **10 passed**.
- Selected dossier/revalidation/nonfunctional/release-gate/formal-review,
  approved-input and real-loop readiness/revalidation adjacency: **121
  passed**.
- `python3 -m py_compile` and targeted `compileall` passed.
- New regressions prove padded, uppercase and non-string section evidence
  hashes fail closed; the shared helper covers signoff and residual-risk
  evidence hashes as well.
- `hermes_workflow_guard.py review-gate --require-verification` is the final
  task gate; release authorization and live clinical/visual/commercial checks
  remain intentionally unrun.

## Delegated-Agent Output Review

- No delegated output was used; Codex performed source inspection and
  verification directly.
- Release readiness, authority-granted=false and control-partition semantics
  were preserved; only hash normalization was removed.

## Residual Risk

The dossier still has no live UAT, provider/runtime identity, source-token/CAS
replay, server authorization, clinical/scientific or visual acceptance, and
the formal reviewer outcomes remain absent. This slice does not clear P10 or
commercial release.
